SEC Form 4 · accession 0001235802-18-000182
DiaMedica Therapeutics Inc. · DMAC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dietrich John Pauls
Officer — President and CEO · Director
Period of report
Dec 11, 2018
Accepted (ET)
Dec 11, 2018 · 4:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001401040
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Voting Common Shares, no par value per shareF1 | Dec 11, 2018 | P | 5,000 | $4.00 | A | 29,804 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 1,749 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan.